中科生物(01237.HK):集團若干出口至美國的木製品將受反補貼税的影響
格隆匯 6 月 15日丨中科生物(01237.HK)公佈,繼2020年1月29日宣佈啟動調查之後,2020年6月9日,美國商務部宣佈對中國進口的木模製品和木製品的反補貼税("反補貼税")調查作出正面之初步裁定,並發現出口商獲得補貼率為13.61%至245.34%的補貼。商務部將指示美國海關和邊境保護局根據該補貼率,向從中國進口木模製品及木製品之進口商收取保證金。
根據上述初步裁定,集團若干出口至美國之木製品將受該反補貼税的影響。集團目前正就美國海關和邊境保護局將收取之保證金與其美國客户與進行談判。
商務部進一步宣佈,目前計劃於2020年10月20日或前後宣佈其反補貼税之最終裁定。如果商務部做出正面之最終裁定,美國國際貿易委員會將計劃於2020年12月3日當天或前後作出最終之損害裁定。
集團將密切監察有關調查的發展,評估對集團的影響,並尋求必要和果斷的行動以儘量減少負面影響
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.